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INTRODUCTION 
Voltage-activated calcium channels in nerve terminals of the neurohypophysis are 
instrumental for triggering the exocytotic release of the neuropeptides, oxytocin (OT) 
and vasopressin (AVP). In depolarization-secretion coupling, Ca2+, acting as a second 
messenger, flows into the terminals through these channels and consequently evokes 
release.'.2 In neurons, the major voltage-gated Ca2+ channels were originally named 
and distinguished as the T- (low-voltage-threshold), N-, and L- (high-voltage- 
threshold)  type^.^,^ Both of the high-voltage Ca2+ channel types may be involved in 
the process of neurotransmitter or neuropeptide 
A number of pharmacological agents, including toxins, have been used to further 
a This work was supported by NIH Grant Nos. NS29470 and AA008003. 
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distinguish these different Caz + channel types. w-Conotoxin GVIA (w-CgTx), a 27 
amino-acid peptide from the venom of the marine snail Conus geogruphus, has 
been shown to block the activity of voltage-sensitive Ca2+ channels and subsequent 
neurotransmitter release in neuronal  tissue^.^.'^ Most previous electrophysiological, 
binding, or release studies have demonstrated that w-CgTx can block the “”’-type 
Ca2+ channels.’’-’3 In contrast, the results obtained with w-CgTx on the long-lasting- 
type Ca2+ channels have been rather inconclusive. The long-lasting-type CaZ+ chan- 
nels have been shown to be insensitive to o-CgTx in many  preparation^.'^.'^ On the 
other hand, it has been shown that long-lasting-type, along with “”’-type, CaZt 
channels were persistently blocked by higher concentrations of W - C ~ T X . ~ , ~ . ” , ’ ~ ~ ~ ~  
Therefore, one cannot exclude possible effects of w-CgTx on the long-lasting-type 
Ca2+ channels and one should question the original claim that w-CgTx binds only 
to “”’-type Caz+ channel^.'^.'^ 
Another useful agent, ( + )-tetrandrine (tetrandrine), a bis-benzylisoquinoline al- 
kaloid (6,6,7,12-tetramethoxy-2,2’-dimethylberbaman), is now employed in China 
for the treatment of hypertension and cardiac arrhythmia. Pharmacological experi- 
ments in vivo and in vitro have explored the mechanisms by which tetrandrine exerts 
its clinical hypotensive and antiarrhythmic effects. Tetrandrine exerted a negative 
inotropic effect on myocardium and blocked high K+-evoked contraction of artery 
strips.I6 It decreased the amplitude of the Ca2+-mediated action potential and inhib- 
ited the inward Ca2+ current in cardiac Purkinje Recent patch-clamp studies 
showed that tetrandrine blocked long-lasting CaZ+ currents in GH3 anterior pituitary 
cells1s and posterior pituitary nerve terminals,19 as well as a low-voltage-activated 
transient channel in adrenal cortical cells.20 Tetrandrine is thereby considered to be 
a new Ca2+ channel blocker, of herbal origin, specific to T and L types. 
Recently, another type of high-voltage-threshold Ca2+ channel, the P-type chan- 
nel, has been characterized in neurons.2‘ Pharmacologically, the P-type channel cur- 
rents are blocked by either a funnel-web spider toxin polyamine (FTX) or peptide 
(w-Agatoxin IVA),22 but are insensitive to other Caz+ channel blockers such as 
w-conotoxin GVIA or the dihydropyridines. The two funnel-web spider toxins there- 
fore provide us with effective probes to distinguish P-type channel current from 
other Ca2+ channel currents. Kinetically, almost all P-type CaZ+ channel currents 
investigated thus far are slowly i n a ~ t i v a t i n g . ~ ” ~ ~ - ~ ~  
It has been reported that FTX eliminated the undershoot of the compound action 
potential, recorded using optical measurement techniques, and reduced the magnitude 
of the action potential in frog neurohypophyseal nerve terminals. After maximal 
inhibition by w-conotoxin GVIA, the active calcium response could be further inhib- 
ited by FTX.26 In addition, a “secretory wave” thought to possibly reflect release of 
peptidergic hormones from the terminal was found to be partially inhibited by either 
FTX or w-conotoxin GVIA. These results imply that at least two populations of 
calcium channels, one being sensitive to w-conotoxin GVIA and another to FTX, 
are present and are required for neuropeptide release in the frog neurohypophyseal 
nerve terminals.27 
The isolated neurohypophyseal nerve terminals of the rat are an accessible model 
system for investigating ionic channels in presynaptic nerve terminals using patch- 
clamp te~hniques.’,~~ Although both a transient, dihydropyridine-resistant N,-type 
and a long-lasting, dihydropyridine-sensitive L-type CaZ+ channel have been pre- 
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viously characterized in the rat neurohypophyseal  terminal^,'^'^^^^ there is still the 
possibility that other types of Ca2+ channel populations exist and function in this 
preparation. In the present study, using the “whole-cell’’ patch-clamp recording 
method, we examined the effects of o-CgTx, tetrandrine, FTX, and o-AgaIVA on 
both the transient and long-lasting components of macroscopic calcium currents (Zca) 
in these nerve terminals. We examined evidence for a voltage-activated P-type Ca2+ 
channel in order to better understand any contributions made by the different types 
of Ca2+ channels to depolarization-secretion coupling in presynaptic terminals. 
MATERIALS AND METHODS 
Terminal Isolation 
Experiments were conducted on the freshly isolated neurohypophyseal nerve ter- 
minals of male CD rats (Charles River Laboratory, Boston, Massachusetts). Briefly, 
as previously d e s ~ r i b e d , ~ ~ ~ ~ ~ ~ ~ ’  the rat, after being anesthetized by COZ, was decapi- 
tated. The brain was removed and then the pituitary gland was excised. After careful 
removal of the anterior pituitary and the pars intermedia, the posterior pituitary was 
homogenized in the following solution (mM): sucrose, 270; HEPES, 10; EGTA, 
0.01; pH 6.8.  The isolated terminals were then placed into a 35-mm petri dish coated 
with poly-l-lysine and perfused with 2.2 mM Ca2+ Locke’s solution (mM): NaCI, 
145; KCl, 5;  CaC12, 2.2; MgCIz, 1; HEPES, 10; glucose, 15; pH 7.3. Typically, the 
peptidergic nerve terminals could be identified using an inverted microscope equipped 
with phase and Hoffman-modulated contrast optics (Nikon, Tokyo, Japan). The 
fact that they are terminals can be confirmed by immunocytochemistry of vasopressin, 
oxytocin, or neu r~phys ins ,~~  and the isolated terminals attached to the bottom of 
the dish have been identified by immunofluorescence staining for vasopressin or 
oxytocin (Thorn and Lemos, unpublished results). Furthermore, after each “whole- 
cell” patch-clamp recording, the peptide contents (AVP or oxytocin) of individual 
terminals can be identified using the dot immunobinding assay.33 Only terminals 
6-9 prn in diameter were chosen for patch-clamping. All experiments were done at  
room temperature (22-24°C). 
“ Whole-Cell” Patch-Clamp Recording 
After approximately one-hour perfusion with 2.2 mM Ca2+ Locke’s solution, the 
terminals were perfused with 10 mM CaZ+ modified Locke’s solution (mM): TEA-Cl, 
100; NaCl, 30; CaC12, 10 (or BaC12, 10); KCl, 5 ;  MgCl2, 1 ;  HEPES, 10; glucose, 15; 
pH 7.3. Pipette solution contained the following (mM): NMG-Cl, 130; EGTA-Cs, 10; 
HEPES, 20; MgATP, 2; cyclic AMP, 0.2; pH 7.2. The resistances of soft glass pipettes 
(Drummond Sci. Company, Broomall, Pennsylvania), which had been double-pulled 
(David Kopf 700C, Tujunga, California), Sylgard-coated, and fire-polished (Nara- 
shige, Kyoto, Japan), were 5-7 M a .  The pipette was pressed against the surface of 
the terminal membrane and mild suction was applied until the giga-seal was formed. 
Additional mild suction could lead to the rupture of the membrane and the “whole- 
14 ANNALS NEW YORK ACADEMY OF SCIENCES 
cell” c~nfiguration.~~ The currents were recorded by using an EPC-7 amplifier (List 
Electronic, Darmstadt, Germany); were filtered at 1-kHz corner frequency, - 3 dB, 
with an 8-pole Bessel filter (902LPF, Frequency Devices Incorporated, Haverhill, 
Massachusetts); and were saved on high-density disks for later analysis. PClamp 
computer software (Axon Corporation, Burlingame, California) and an A-D con- 
verter (homemade) were used to generate command voltage potentials. 
Drug Application 
Most of the terminals were picked up from the bottom of the petri dish after 
giga-seal formation so that the entire area of their membrane would have direct 
contact with the perfused medium. The “rundown” of Zca in the neurohypophyseal 
nerve terminal was so fast that, in most cases, Ica values for the control and the 
drug-treated were recorded from separate terminals. FTX, purified chromatographi- 
cally from the crude venom of American funnel-web spiders (Agelenopsis aperta), 
was a kind gift from R. Llinas and B. Cherksey (Department of Physiology and 
Biophysics, New York University Medical Center). w-AgaIVA purified from the same 
venom was a kind gift of Michael E. Adams (Department of Entomology, University 
of California at Riverside). o-Conotoxin GVIA (Peninsula Laboratories) was pre- 
pared as 40 mM stock solution in 2% BSA solution. Tetrandrine, an alkaloid extracted 
from the root of Stephania tetrandra S. Moore, was a kind gift from X. G. Zong 
(Institute of Pharmacology and Toxicology, Technical University of Munich). 
Release Assays 
For release studies, the isolated terminals are resuspended in normal saline and 
loaded on a 0.22-pm Millipore filter. After experimental manipulations, perfusate 
samples are then collected. Hormone release is determined by radioimmunoassay, 
as described p rev io~s ly .~~~”  AVP and OT antibodies are used at a final concentration 
of 1/80,000 and 1/40,000, respectively. The cross-reactivity of OT in the AVP assay 
is less than 1: 1000. Similarly, the cross-reactivity of AVP in the OT assay is less than 
1 :200. 
Data Analysis 
PClamp software was also used for analysis of the data. The inward Zca was 
expressed as downward. In most cases, the leakage currents were subtracted from 
the total currents in order to analyze the pure inward ZC.. The amplitude of Zca at 
the end of the 200-ms steps was considered to be that of the long-lasting component 
of the Zca, and the difference in amplitude between this component of Ica and the 
peak Zca is considered to be that of the transient Zca (see FIGURE 1B). Data are given 
as mean f SEM. Student’s t test was used to examine statistical significance of paired 
or unpaired data. 
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FIGURE 1. The transient- and long-lasting-type components of neurohypophyseal termi- 
nal ZCa. (A) An example of current traces recorded from a nerve terminal in 10 mM Ca2+ 
bath solution. Current obtained from a holding potential (HP) of - 90 mV, stepping to 
+ 10 mV. Zca disappears in 0 Ca2+ (replaced by 10 mM TEA-C1) bath solution. The 
complete Zca can be washed back after returning to 10 mM Ca2+ bath solution. (B) The 
inactivating phase of ZC. exhibits two exponential functions: a fast-inactivating, transient 
(Tr) component with a ~i of - 30 ms and a slow-inactivating, long-lasting (LI) component 
with a ~i of - 1000 ms. Normally, the last 100 (minimum) points in the trace were averaged 
in order to measure the long-lasting (Ll) component. This value was subtracted from the 
peak (total) current to provide a measurement of the transient (Tr) component. The dashed 
line represents baseline current and the solid line is the fit to the L1 component. 
RESULTS 
Long-lasting and Transient Components of IcC in Peptidergic Nerve Terminals 
We recorded, by stepping to + 10 mV from -90 mV, a macroscopic calcium 
current (Ica) from individual, isolated nerve terminals (as shown in FIGURE IA), 
whose peak followed a TTX-sensitive INa nd which consisted of fast-inactivating 
(transient) and slowly inactivating (long-lasting) components.' Furthermore, both 
components of the inward current can be abolished by either removing all CaZ+ 
(FIGURE 1A) or adding 50 pM Cd2+ to the bathing solution.29 Thus, the inward 
currents are indeed Ica. Under control conditions, because the slow activation ( -  10 
ms) of the long-lasting Ca2+ current contaminates the faster activation ( -  2 ms) and 
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inactivation (23 ms) of the transient-type Ca2+ current as elicited by a depolarization 
from - 90 mV to + 10 mV,’s2’ the distinction between the two Ca2+ current compo- 
nents during a 250-ms pulse is not completely obvious; however, it is nevertheless 
possible to differentiate the two phases of the total current (see FIGURE 1B). The 
inactivating phase of the current evoked from a holding potential (HP) of - 90 mV 
can be fitted with the sum of two exponentials (see FIGURE IB): one is a rapidly 
decaying transient component with a time-constant of inactivation (ri) of 30-40 ms, 
corresponding to the transient type; the other is a long-lasting component with a zi 
of 700-1000 ms, corresponding to  the long-lasting Thus, only the long-lasting 
component is evident a t  the end of these 150-ms-long traces. This observation has 
been used in protocols to  separate the two components using “whole-cell”recordings.29 
The long-lasting-type component of Zca can be more selectively activated by holding 
at  a potential of - 50 mV (FIGURE 2B), where the rapidly decaying transient compo- 
nent is This protocol might be the most effective in isolating the long- 
lasting-type component. 
w-CgTx Inhibits Both Components of Ic,, 
In these studies, control and experimental measurements were carried out on 
different terminals (unless otherwise mentioned in the text) to  avoid the complications 
associated with “rundown” or “washout” of ZCa.35 ZCa “rundown” can occur very 
rapidly, within 3-5 minutes, in these nerve terminals. On the other hand, because 
o-CgTx is known to irreversibly block Ca2+ channels,“ no recovery of currents can 
be obtained. Our strategy for this toxin, in particular, was the following: Currents 
from a number of individual terminals were recorded immediately after breakthrough 
while in the control perfusion pipette. Currents from another group of terminals in 
the same dish were recorded while in the same perfusion pipette, but containing 
w-CgTx. In control studies, we found that the untreated terminals did not show a 
change in baseline Zca during time periods (3-4 h) longer than those that separated 
the first control group and the last drug-treatment group.29 
FIGURE 2A shows representative inward current records elicited by stepping to 
+ 10 mV (peak response) from a holding potential of - 90 mV in the absence and 
presence of different concentrations of w-CgTx. The amplitude of the peak transient- 
type Ica was significantly reduced at  a concentration of 30 nM w-CgTx (FIGURE 
2C) and the inhibition was dose-dependent, The half-maximal inhibition ( I G )  of 
transient-type Zca by o-CgTx was calculated to  be 50 nM. At higher concentrations, 
we found that w-CgTx also reduced the long-lasting component of the Ica. FIGURE 
2B shows representative inward current records elicited by stepping to  + 10 mV from 
a holding potential of - 50 mV in the absence and presence of different concentrations 
of o-CgTx. The amplitude of the peak long-lasting Zca was significantly reduced at  
a concentration of 300 nM w-CgTx (FIGURE 2D) and this reduction was dose- 
dependent. The half-maximal inhibition (ICso) of long-lasting-type current by o-CgTx 
was calculated to  be 513 nM. Even at  the highest concentration (2 pM) tested, how- 
ever, an appreciable amount ( -  20%) of transient Zca remained (FIGURE 2C). 
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FIGURE 2. Effects of w-CgTx on the terminal ZC~. (A) Representative traces of the tran- 
sient-type component of Ica, elicited as in FIGURE 1A, inhibited by w-CgTx at the concentra- 
tions as noted at right. (B) Effects of w-CgTx on the long-lasting-type component elicited 
as indicated above. Representative traces of Zca inhibited by w-CgTx at the concentrations 
as noted at right. (C)  Dose-response relationship shows the mean +_ SEM (n = 5-9) 
amplitudes of Tr peak currents, as measured in FIGURE lB, elicited by a voltage step as 
indicated above in the absence or presence of various o-CgTx concentrations. These data 
were fit (dashed line) using the Langmuir adsorption isotherm, y = B,,, . (l/[x/(ICso + 
x ) ] ] ,  where x is the CgTX concentration. (D) Dose-response relationship shows the mean 
f SEM (n = 5-10) amplitudes of the peak currents, elicited as in part B, in the absence 
or presence of various w-CgTx concentrations. These data were also fit (dashed line) using 
the Langmuir adsorption isotherm. Modified from reference 29. 
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Inhibition of A VP Release by w-CgTx 
The above findings corroborate peptide reIease studies from the same preparation. 
Release of the peptide hormones, arginine vasopressin (AVP) and oxytocin, from 
these nerve terminals can be measured by radioimmunoassay (for review, see reference 
32). The binding of o-CgTx to specific receptors on these nerve terminals and its 
effects on high potassium and electrically induced release of AVP have been exam- 
i ~ ~ e d . ~ ’  There is a high affinity for o-CgTx in these terminals and, a t  nM concentra- 
tions, the toxin can inhibit both high K’ and electrically stimulated AVP release 
from the nerve terminals of the neurohypophysis (FIGURE 3 ) .  The maximum inhibition 
of release, however, was only 78%, even at the highest (300 nM) concentration tested 
(FIGURE 3 ,  inset). This was true even when maximal concentrations of DHP antagonist 
and a-CgTx were added together.” In order to  determine what other, if any, Ca2+ 
channels could underlie the resistant Ca2+ -dependent release, other toxins were tested. 
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FIGURE 3. Effects of w-CgTx on high K’ and electrically stimulated AVP release. The 
neural lobe was stimulated with a pattern of firing mimicking the electrical activity of 
magnocellular neurons of the hypothalamus. Ten nM o-CgTx (closed circles) inhibited 
the evoked AVP release down to 28% of control (open circles). Insert: Dose-response 
curve of w-CgTx effects on high (100 mM) K +-evoked AVP release. The results are given 
as mean & SEM (4 < n < 7). Modified from reference 31. 
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Dose-dependent Inhibition of the Transient Ica by External FTX 
The effects of funnel-web spider toxin (FTX), a polyamine that reportedly specifi- 
cally blocks P-type Ca2+ channels,36 on the Ca2+ currents of the neurohypophyseal 
nerve terminals were investigated. The long-lasting Ica component elicited by depolar- 
izations from HP = - 50 mV was insensitive to  the external application of high 
doses of FTX (FIGURE 4), except for the residual transient component normally seen 
at this HP.Z9 FTX had little effect on the long-lasting Ica component at any voltage 
(FIGURE 4a), but there is an approximately 10-mV depolarizing shift in theZ-V relation- 
ship of the long-lasting Ica ~omponent .~’  The transient component of Zca elicited 
from -90 mV, however, was significantly inhibited by externally applied FTX in a 
dose-dependent manner (FIGURE 4b). This inhibition by FTX could be reversed by 
washing. 
Inhibition of Long-lasting Component of Ica by Tetrandrine 
In FIGURE 5A, the external application of 33 pM tetrandrine, a bis-benzyl- 
isoquinoline alkaloid, strongly inhibited the long-lasting Ica, whereas the Z N ~  and 
the transient-type Zca remained unaffected.I9 The ICso for tetrandrine to  inhibit the 
noninactivating Ca2+ current is 10.1 pM.’9*3s The transient-type Zca could only be 
partially inhibited if the concentration of tetrandrine was increased to 50 pM. Any 
FIGURE 4. Effects of external application of FTX on high-voltage-activated ZG recorded 
from isolated rat neurohypophyseal nerve terminals using the “whole-cell” configuration. 
(a) Representative traces of the long-lasting Zca elicited by steps from HP = - 50 mV to 
the voltages indicated. As much as 0.5 pL/mL FTX failed to affect this current. (b) 
Representative traces of both transient and long-lasting Ica elicited by stepping from 
H P  = - 90 mV to the voltages indicated. There is a reduction by FTX of the amplitude 
of only the transient component of Ic,. 
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FIGURE 5. Effects of external application of tetrandrine on I c ~  recorded from rat neuro- 
hypophyseal nerve terminals using the “whole-cell” configuration. (A) The ZC, values in 
control conditions and in the presence of tetrandrine were recorded from different termi- 
nals. The current was maximally elicited by a depolarization from -90 mV to + 10 mV. 
Note that the initial, faster has been cut off in this figure. The dashed lines indicate 
the baselines of the currents. (B) The I-V curves of the L-type Zca in control conditions 
(0) and in the presence of 3 pM (V), 10 ]*M (V), and 30 pM (0) tetrandrine. (C)  Voltage- 
dependence of inhibition of the L-type Zca by tetrandrine. The ratios of currents (ln[(Io/Zb) : 
11, where I, and Ib are the control and the blocked current, respectively) of the macroscopic 
L-type Zca (0) were plotted against the step potentials using the results of control versus 
10 pM tetrandrine from part B. Modified from reference 19. 
effect of tetrandrine on  the inactivated time-constant of transient-type Zca was evalu- 
ated as well. The mean time-constant of the total Zca treated with 33 WM tetrandrine 
appeared to be decreased to  16 f 3.5 ms (n = 4) from 72.7 f 16 ms of the control 
(n = 3), but this is similar to the time-constant for inactivation (23 ms) of the isolated 
transient component.’ Moreover, treatment with a higher concentration (50 pM) of 
tetrandrine did not further reduce the inactivation time-constant (17.8 * 8.2 ms, 
n = 3), indicating that tetrandrine has n o  direct effect on the inactivating rate of 
the transient-type Zca. Inhibition of both Zca components could be reversed by washing. 
In order to  evaluate any voltage-dependence of inhibition of the L-type Ica by 
tetrandrine, we examined its effects a t  different step potentials. The I-V curves of 
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this current, in the absence and presence of tetrandrine, reveal that the inhibition 
by tetrandrine of the L-type Ica is not proportionally the same at each potential 
(FIGURE 5B). Examination of the plot of ln[(Z,/Zb) - I] against membrane potential 
(FIGURE 5C) demonstrates that the slope of the inhibition for the L-type Zca is 14, 
about 11 times steeper than that for ZK(C~), indicating that tetrandrine’s inhibition of 
the noninactivating Zca is strongly voltage-dependent . I 9  
FTX-sensitive Ica versus Tetrandrine-insensitive Ic,, 
In order to avoid any dihydropyridine-dependent artifacts, we chose tetrandrine, 
a nondihydropyridine L-type Ca2+ channel blocker (see references 19 and 38, as well 
as above), to block the long-lasting Ca2+ current. Thus, we could more clearly examine 
the interaction of FTX with the remaining transient Zca. FTX could fully inhibit 
the remaining transient Zca in a dose-dependent manner (FIGURE 6A). Fitting the 
dose-response curve using the Langmuir adsorption isotherm to the data gave an 
ICso of 0.04 pL/mL (FIGURE 6B). A pipette-perfusion system was utilized to apply 
FTX to a terminal so rapidly that the ZBa could be recorded under both control 
conditions and in the presence of FTX before obvious “rundown” of the current 
could take place. As illustrated in FIGURE 7, 0.1 pL/mL FTX eliminated only the 
inactivating ZBa, whereas the long-lasting lea remained unaffected. The FTX-sensitive 
(upper trace) is the difference between control Z B ~  and FTX-treated zBa.37 
o-AgaZVA Effects on Neurohypophyseal Terminal Ica 
The funnel-web spider polypeptide toxin, w-AgaIVA, potently and specifically 
blocks P-type CaZ+ channels in neuronal cell b ~ d i e s . ~ ~ , ’ ~  FIGURE 7 shows that the 
inhibition of the inactivating Ca2+ current by w-AgaIVA-toxin appears similar to 
that observed using the polyamine, FTX. The inactivating Ca” current was strongly 
inhibited by externally applied o-AgaIVA with an ICSO of approximately 15 nM.39 
In contrast, the noninactivating Ca2+ current was not significantly affected by the 
same concentration of o-AgaIVA. Thus, o-AgaIVA is a potent blocker of the high- 
threshold, fast-inactivating Caz+ current of neurohypophyseal  terminal^.^' 
The neurohypophyseal transient CaZ+ current shows voltage-dependent recovery 
from block by o-AgaIVA (FIGURE 8). Trains of strong depolarizations (to + 80 mV) 
were able to apparently “knock off the peptide toxin from the terminal Ca2+ channel, 
as has been reported for neuronal cell bodies.24 
Block of the Transient Ica by a Combination of o-Conotoxin GVIA and FTX 
We have shown that extracellular o-conotoxin GVIA dose-dependently inhibited 
the transient Zca in the nerve terminals, but with a maximal reduction of about 8 0 V 0 . * ~  
Because the present results demonstrate that the funnel-web spider toxins are also 
able to inhibit the transient Zc, it seemed necessary to test if the o-conotoxin GVIA- 
resistant Zca could be further affected by the spider toxins. As illustrated in FIGURE 
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FIGURE 6. FTX blocks the tetrandrine-resistant component of Zce of the nerve terminals. 
(A) Zca was elicited by stepping from -90 mV to + 10 mV as indicated. The external 
application of tetrandrine produced profound inhibition on the long-lasting Zca (see FIGURE 
5A). The remaining transient Zca could be blocked by FTX in a dose-dependent manner. 
These effects could be reversed by washing. (B) The dose-response inhibition by FTX of 
the tetrandrine-resistant transient Zca could be fit using the Langmuir adsorption isotherm, 
giving an ICSo = 0.1 pL/mL. This is from a total of 16 terminals ( 5  controls, 2 at 0.01, 
4 at 0.1, 3 at 0.25, and 2 at 0.5 pL/mL FTX). 
9, after pretreatment with 700 nM w-conotoxin GVIA, the amplitudes of transient 
and long-lasting calcium currents, when the terminals were depolarized by stepping 
from -90 mV to 0 mV, were 88.4 f 6.7 pA and 75.2 k 2 PA, respectively (n = 
3). If 700 nM w-conotoxin GVIA and 0.25 pL/mL FTX were simultaneously present 
in the bath solution, the amplitudes of transient Zca were reduced to  9.8 k 10.9 pA 
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FIGURE 7. Similar inhibition by FTX and a-AgaIVA of the transient ZBa (using 10 mM 
Ba2+ solution) of the neurohypophyseal terminals. Using the perfusion pipette, FTX (0.1 
pL/mL) was externally applied to the same terminal following a control recording by 
stepping as indicated above. The FTX-treated current was subtracted from the control 
to obtain the FTX-sensitive (upper). Similarly, treatment with 15 nM a-AgaIVA re- 
sulted in an w-AgaIVA-sensitive &* (lower). The dashed lines are baseline currents. 
(n = 4, P < 0.01), whereas the amplitudes of long-lasting Ica were not significantly 
affected (83.6 k 5 PA, n = 4, P > 0.05). Thus, FTX can effectively block the 
w-CgTx-resistant transient Ca'' current of neurohypophyseal terminals. 
Effects of FTX on A VP Release 
FIGURE 10 shows preliminary evidence that high K+-induced release of AVP was 
partially (22Vo) inhibited by a high dose (0.5 pL/mL) of FTX. Whether this partial 
reduction can be attributable to  a P-type channel component and/or if this corre- 
sponds to  the Ca2+-dependent release that has been shown t o  be resistant to organic 
blockers requires more experiments. Taken together, these data strongly suggest that, 
in these nerve terminals of the neurohypophysis, multiple types of ICa are important 
for peptide release. 
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FIGURE 9. FTX blocks the w-conotoxin GVIA-resistant component of the transient Zca. 
The transient Ic., elicited by stepping to + 10 mV from -90 mV, could be partially 
inhibited by external application of 700 nM w-conotoxin GVIA (top). Addition of 0.25 
pL/mL FTX to the 700 nM a-conotoxin GVIA in the bath could significantly reduce the 
amplitude of the transient I=. that is resistant to w-conotoxin GVIA (bottom). The dashed 
lines are baseline currents. 
DISCUSSION 
Two Kinetically Distinct Components of Ica 
There are at least two different (transient and long-lasting) types of high-threshold, 
voltage-gated CaZ+ channels in the isolated neurohypophyseal peptidergic nerve ter- 
m i n a l ~ . ~ ~ * ~  The properties of the two types of Caz+ channels in these nerve terminals 
have been previously studied using single-channel patch-clamp  technique^.^ The tran- 
sient channels had a smaller conductance, high threshold for activation, were inacti- 
vated rapidly, and also were not sensitive to  dihydropyridines. The long-lasting-type 
channels, which inactivated slowly, had a larger conductance, high threshold for 
activation and were dihydropyridine-sensitive to both agonists and antagonists. 
a-CgTx can reduce both the transient and long-lasting components of Zca in these 
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FIGURE 10. FTX effects on high K+-stimulated AVP release. AVP release was stimulated 
by high (50 mM) potassium as indicated by the solid bars with the K above. FTX (0.5 
pL/mL) was applied (solid bar) only during the second stimulation. All experiments were 
performed in 40 mM Na' saline so as not to reduce Na' and increase K' at the same 
time. 
nerve terminals. The effects on the transient type are in agreement with many previous 
findings showing that o-CgTx can block '""-type Ca2+ channels. However, our 
studies have demonstrated that the long-lasting-type component of Ica can also be 
reduced by higher concentrations of w-CgTx, suggesting that long-lasting-type Ca2+ 
channels might also be sensitive to w-CgTx, although 10 times less so than the transient 
type. Nevertheless, w-CgTx can affect the long-lasting-type Caz+ channels in these 
nerve terminals. These findings corroborate AVP release studies from the same prepa- 
ration. The influx of CaZ+ via membrane voltage-gated channels is usually associated 
with transmitter release from nerve terminals. The activation of the long-lasting-type 
Ca2' channels is the main factor for inducing an increase in cytoplasmic CaZ+ (see 
references 40 and 41) and in AVP release.8 AVP release from the nerve endings, 
which is also highly sensitive to dihydropyridine~,~~ can be strongly inhibited by 
o-CgTx (FIGURE 3).3' 
Previous electrophysiological s t ~ d i e s , ~ ~ . ' ~  together with our present data, have 
shown that Ica is not completely blocked by this toxin. Even though the L-type 
channels are selectively blocked by nifedipine and the ""'-type channels by w-CgTx, 
recent studies by Schroeder and  colleague^^^ on rat dorsal root ganglion neurons 
have shown that the two together fail to block all of Zc,. Biochemical studies3' also 
showed that w-CgTx could not totally abolish the rise in nerve terminal free internal 
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Ca2+ concentrations induced by high potassium depolarization and that, subse- 
quently, a small, but substantial amount (- 20%) of AVP release was insensitive to 
both this toxin and the dihydropyridines. 
Other Types of Ca’+ Channels in Neurohypophyseal Terminals? 
In order to determine what other, if any, Ca2+ channels could underlie the above- 
mentioned resistant Ca2+ -dependent release, other toxins were tested. Tetrandrine, 
a Chinese plant toxin, has a strong hypotensive action due not only to vasodilation, 
but also possibly due to its inhibiting the release of vasopressin from the neurohypo- 
physeal terminals. Tetrandrine has been reported to have verapamil-like actions on 
the cardiovascular system.16 Binding studies showed that tetrandrine blocked diltia- 
zem and D-600 binding, but stimulated nitrendipine binding.’* It has been shown to 
be a more effective blocker of “T”-type versus “L”-type ~ h a n n e l s . ~ ~ , ~ *  Our results 
indicate that the inhibition by the alkaloid of the long-lasting Zca differs from that 
of the transient-type Zca in that lower concentrations (3-33 pM) block only the long- 
lasting Caz+ channel; however, at higher concentrations ( 2 5 0  pM), it could also 
block the transient-type Ca2+ channel. This is another bit of evidence showing that 
the transient Zca in the terminals is not a T-type channel. Our results show that the 
ICso for tetrandrine’s effect on the long-lasting Ca2+ current of nerve terminals is 
10.1 pM, almost identical to that observed for vessel smooth muscles in vitro.I6 The 
fact that the ability of tetrandrine to inhibit the long-lasting Ca2+ channel current 
was strongly enhanced by depolarization (FIGURE 5C) could account for its voltage- 
dependent negative inotropism on the myocardium.16 
Venom of the funnel-web spider, Agelenopsis aperta, contains the polyamine FTX 
and the peptide a-AgaIVA. The present findings showing that FTX potently inhibits 
the transient component of Zca in these nerve terminals, with little effect on the 
long-lasting Ica, indicate that there are structural differences in the Ca2+ channels 
underlying these Zca. Because this toxin has been shown to be a specific P-type Ca2+ 
channel b l o ~ k e r , ~ ~ * ~ ~ , ~ ~ , ~ ~  it should nominally be a P-type Ca2+ channel that underlies 
the FTX-sensitive transient Zca in the neurohypophyseal nerve terminals. However, 
the high-threshold Ca2+ conductances sensitive to FTX or o-Agatoxin IVA in neu- 
ronal cells and expressed in Xenopus oocytes from rat brain mRNA show little 
i n a c t i v a t i ~ n . ~ ’ * ~ ~ - ~ ~  It is not clear why the kinetics of the funnel-web spider toxin- 
sensitive Ca2+ conductance in these nerve terminals are quite different, but they are 
similar to each other in terms of sensitivity to the spider toxins and in single channel 
conductance. 
Conclusions 
There are at least two (transient and long-lasting) types of high-threshold, voltage- 
activated Ca2+ channels that coexist in the peptidergic nerve terminals of the rat 
neurohypophysis. w-CgTx can block both types of Ca2+ channels, but with the tran- 
sient type being 10 times more susceptible. This toxin also strongly inhibited the 
potassium and electrically induced release of vasopressin from the neurohypophyseal 
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nerve terminals. The results from these two observations indicate that a Ca2+ channel 
with a high affinity for w-conotoxin GVIA binding in the terminals underlies the 
transient Zca that plays an important role in depolarization-secretion coupling of 
neurohormones. However, a small, but significant depolarization-induced vasopres- 
sin release is insensitive to both w-conotoxin GVIA and the dihydropyridine antago- 
nist ni~ardipine,~’ indicating that there could be another CaZ+ channel involved in 
this process. Preliminary data (see FIGURE 10) indicate that FTX can also inhibit 
Ca2+-dependent peptide r e l e a ~ e . ~ ~ . ~ ’  Taken together, these data strongly suggest that, 
in these nerve terminals of the neurohypophysis, more than two types of Zca are 
important for peptide release. 
Our findings show that FTX and w-AgaIVA, like w-conotoxin GVIA, can inhibit 
the transient Zca in the nerve terminal. Possible mechanisms that could account for 
these overlapping inhibitions of the transient Zca could be as follows: First, whereas 
the w-conotoxin GVIA-sensitive Ca2+ channel underlies only a portion of the tran- 
sient Zc,, the funnel-web spider toxin-sensitive Ca2+ channel underlies the remainder 
of the transient Zc,. Therefore, the high-threshold, inactivating Ca2+ current in these 
isolated nerve terminals has a “P”-type Ca2+ channel component that is, however, 
different in its inactivation from previously reported “P”-type Ca2+ currents. Second, 
there may be binding sites for both w-conotoxin and the funnel-web spider toxins 
on the same “novel” channel underlying the transient Zc,. These differences in structure 
and function and in the interactions of the blockers with the inactivating Ca2+ conduc- 
tance need to be probed by more direct methods, such as single channel recording. 
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